Dr. Heyman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
900 Caton Ave
Baltimore, MD 21229Phone+1 667-234-2910Fax+1 667-234-3517
Education & Training
University of MarylandResidency, Internal Medicine, 1970 - 1974
University of Maryland School of MedicineClass of 1970
Certifications & Licensure
MD State Medical License 1970 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- Sorafenib in Treating Patients With Recurrent Non-Hodgkin's Lymphoma Start of enrollment: 2005 Oct 01
Publications & Presentations
PubMed
- 13 citationsLymphocytosis of large granular lymphocytes in patients with hodgkin's diseaseDorothea Kingreen, Bakul I. Dalal, Meyer R. Heyman, Gordon L. Phillips, Doug Horsman
American Journal of Hematology. 1995-12-01 - 28 citationsPneumocystis carinii involvement of the bone marrow in acquired immunodeficiency syndrome.Meyer R. Heyman, Peter Rasmussen
American Journal of Clinical Pathology. 1987-06-01 - 32 citationsPhase I Clinical Trial of the Inosine Monophosphate Dehydrogenase Inhibitor Mycophenolate Mofetil (Cellcept) in Advanced Multiple Myeloma PatientsNaoko Takebe, Xiangfei Cheng, Suhlan Wu, Kenneth S. Bauer, Olga Goloubeva
Clinical Cancer Research. 2004-12-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
